Tykerb approved for metastatic breast cancer treatment in combination with letrozole - MPR
Links shared publicly online about this topic.
- 1,413total visits
Tykerb approved for metastatic breast cancer treatment in combination with letrozole - MPR
empr.com —
View full resource at empr.com
Tags: Breast Cancer, Breast Cancer Medication, Metastatic Breast Cancer, Women's Health, FDA, Femara, Novartis, GlaxoSmithKline
Most Recently Shared on February 1, 2010 at 4:03 pm By:
MPR News: Tykerb approved for metastatic breast cancer treatment in combination with letrozole: GlaxoSmithKline an... http://bit.ly/bXPrOd
GSK's TYKERB(R) Receives Accelerated Approval For First-Line Combination Treatment Of Metastatic Breast Cancer
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB® (lapatinib) as a first-line” View full resource at medicalnewstoday.com
Most Recently Shared on February 2, 2010 at 2:10 pm By:
GSK's TYKERB(R) Receives Accelerated Approval For First-Line Combination Treatment Of Metastatic Breast Cancer http://mnt.to/3x4y
FDA approves lapatinib plus letrozole for HER-2–positive, HR-positive, metastatic breast cancer | HemOncToday
hemonctoday.com — “The FDA has announced its accelerated approval of the combination of lapatinib plus the aromatase inhibitor letrozole for the treatment of ho” View full resource at hemonctoday.com
Most Recently Shared on February 1, 2010 at 3:39 pm By:
FDA approves lapatinib plus letrozole for HER-2–positive, HR-positive, metastatic breast cancer http://ow.ly/12Act
GSK’s TYKERB receives accelerated approval for first-line combination treatment of metastatic breast cancer
us.gsk.com — “not named” View full resource at us.gsk.com
Most Recently Shared on February 1, 2010 at 2:33 pm By:
GSK’s TYKERB receives accelerated approval for first-line combination treatment of metastatic breast cancer - http://ow.ly/12ytk
Advertisement

